Surmodics (SRDX) News Today $38.72 +0.63 (+1.65%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Surmodics (NASDAQ:SRDX) Now Covered by Analysts at StockNews.comStockNews.com assumed coverage on Surmodics in a report on Friday. They set a "hold" rating on the stock.November 15 at 3:15 AM | marketbeat.comFY2026 EPS Estimates for Surmodics Increased by AnalystSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Investment analysts at Barrington Research increased their FY2026 earnings per share (EPS) estimates for Surmodics in a report released on Thursday, November 7th. Barrington Research analyst M. Petusky now anticipates that the company will earn $0.89November 11, 2024 | marketbeat.comNisa Investment Advisors LLC Has $42,000 Stock Position in Surmodics, Inc. (NASDAQ:SRDX)Nisa Investment Advisors LLC lessened its holdings in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 98.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,093 shares of the company's stock after selling 67,336 shares durNovember 9, 2024 | marketbeat.comBarrington Research Lifts Earnings Estimates for SurmodicsSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Stock analysts at Barrington Research increased their FY2025 earnings per share (EPS) estimates for shares of Surmodics in a report issued on Thursday, November 7th. Barrington Research analyst M. Petusky now forecasts that the company will post earniNovember 8, 2024 | marketbeat.comSurmodics Inc. Reports Q4 and FY 2024 ResultsNovember 7, 2024 | markets.businessinsider.comHold Rating Maintained for SurModics Amid Acquisition UncertaintyNovember 7, 2024 | markets.businessinsider.comOlympiad Research LP Takes Position in Surmodics, Inc. (NASDAQ:SRDX)Olympiad Research LP bought a new stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 48,591 shares of the company's stock, valued at approximately $1,884,000. Surmodics aNovember 7, 2024 | marketbeat.comNeedham & Company LLC Reiterates Hold Rating for Surmodics (NASDAQ:SRDX)Needham & Company LLC reaffirmed a "hold" rating on shares of Surmodics in a research report on Thursday.November 7, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Stock Price Passes Above 200-Day Moving Average - Time to Sell?Surmodics (NASDAQ:SRDX) Share Price Crosses Above Two Hundred Day Moving Average - Here's What HappenedNovember 7, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Now Covered by StockNews.comStockNews.com started coverage on shares of Surmodics in a research report on Thursday. They set a "hold" rating on the stock.November 7, 2024 | marketbeat.comSurmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy SystemOctober 30, 2024 | businesswire.comSurmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.comStockNews.com started coverage on shares of Surmodics in a report on Wednesday. They issued a "hold" rating on the stock.October 30, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.comStockNews.com began coverage on Surmodics in a research report on Tuesday. They issued a "hold" rating for the company.October 22, 2024 | marketbeat.comMillennium Management LLC Trims Holdings in Surmodics, Inc. (NASDAQ:SRDX)Millennium Management LLC trimmed its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 86.8% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 76,997 shares of the company's stock after selling 506,030 shares during the period. Millennium ManagemOctober 15, 2024 | marketbeat.comStockNews.com Initiates Coverage on Surmodics (NASDAQ:SRDX)StockNews.com began coverage on shares of Surmodics in a research report on Monday. They issued a "hold" rating on the stock.October 14, 2024 | marketbeat.comSurmodics, Inc. Expected to Earn FY2025 Earnings of $0.13 Per Share (NASDAQ:SRDX)Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Research analysts at Zacks Research upped their FY2025 earnings per share (EPS) estimates for Surmodics in a research report issued on Wednesday, October 9th. Zacks Research analyst D. Dey now forecasts that the company will post earnings per share ofOctober 14, 2024 | marketbeat.comAQR Capital Management LLC Cuts Position in Surmodics, Inc. (NASDAQ:SRDX)AQR Capital Management LLC lessened its position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 53.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,228 shares of the company's stock afOctober 13, 2024 | marketbeat.com13,722 Shares in Surmodics, Inc. (NASDAQ:SRDX) Acquired by Algert Global LLCAlgert Global LLC acquired a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 13,722 shares of the company's stock, valued at approximately $577,000. Algert Global LLC owned about 0.10%October 7, 2024 | marketbeat.comWater Island Capital LLC Makes New $1.16 Million Investment in Surmodics, Inc. (NASDAQ:SRDX)Water Island Capital LLC acquired a new stake in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 27,592 shares of the company's stock, valued at approximately $1September 30, 2024 | marketbeat.comDisciplined Growth Investors Inc. MN Sells 78,609 Shares of Surmodics, Inc. (NASDAQ:SRDX)Disciplined Growth Investors Inc. MN lowered its holdings in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 11.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 580,566 shares of the company's stock afterSeptember 29, 2024 | marketbeat.comStockNews.com Begins Coverage on Surmodics (NASDAQ:SRDX)StockNews.com initiated coverage on Surmodics in a research note on Saturday. They issued a "hold" rating on the stock.September 28, 2024 | marketbeat.comSurmodics, Inc. (SRDX)September 24, 2024 | finance.yahoo.comSagefield Capital LP Invests $2.35 Million in Surmodics, Inc. (NASDAQ:SRDX)Sagefield Capital LP acquired a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 55,900 shares of the company's stock, valued at appSeptember 24, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Bought by Renaissance Technologies LLCRenaissance Technologies LLC boosted its holdings in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 5.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 606,538 shares of the company's stock aftSeptember 20, 2024 | marketbeat.comGardner Lewis Asset Management L P Buys Shares of 202,934 Surmodics, Inc. (NASDAQ:SRDX)Gardner Lewis Asset Management L P purchased a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 202,934 shares of the company's stock, valued at appSeptember 18, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Receives New Coverage from Analysts at StockNews.comStockNews.com initiated coverage on Surmodics in a report on Thursday. They issued a "hold" rating for the company.September 12, 2024 | marketbeat.comTrium Capital LLP Takes $1.41 Million Position in Surmodics, Inc. (NASDAQ:SRDX)Trium Capital LLP purchased a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 33,434 shares of the company's stock, valued at approximSeptember 9, 2024 | marketbeat.comWolverine Asset Management LLC Takes Position in Surmodics, Inc. (NASDAQ:SRDX)Wolverine Asset Management LLC bought a new position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 25,966 shares of the company's stock, valued at approximately $1,092,000. WSeptember 5, 2024 | marketbeat.comVersor Investments LP Purchases Shares of 64,770 Surmodics, Inc. (NASDAQ:SRDX)Versor Investments LP acquired a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 64,770 shares of the company's stock, valued at approximately $2September 2, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Short Interest UpdateSurmodics, Inc. (NASDAQ:SRDX - Get Free Report) saw a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 462,000 shares, a decrease of 36.9% from the July 31st total of 732,100 shares. Based on an average daily volume of 466,400 shares, the short-interest ratio is currently 1.0 days. Approximately 3.4% of the shares of the stock are sold short.August 28, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Nisa Investment Advisors LLCNisa Investment Advisors LLC grew its stake in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 4,722.3% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,429 shares of the company's stock after purchasingAugust 21, 2024 | marketbeat.comSurmodics, Inc. Expected to Earn FY2024 Earnings of ($0.47) Per Share (NASDAQ:SRDX)Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities researchers at Zacks Research lifted their FY2024 earnings per share estimates for shares of Surmodics in a research report issued on Wednesday, August 14th. Zacks Research analyst D. Dey now expects that the company will post earnings per shAugust 19, 2024 | marketbeat.comZacks Research Analysts Increase Earnings Estimates for Surmodics, Inc. (NASDAQ:SRDX)Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Research analysts at Zacks Research lifted their Q1 2026 earnings estimates for Surmodics in a report released on Wednesday, August 14th. Zacks Research analyst D. Dey now forecasts that the company will post earnings per share of $0.22 for the quarteAugust 16, 2024 | marketbeat.comHold Rating Maintained Amid SurModics Acquisition Delays and FTC ScrutinyAugust 15, 2024 | markets.businessinsider.comSurmodics (NASDAQ:SRDX) Sees Unusually-High Trading VolumeSurmodics (NASDAQ:SRDX) Sees Strong Trading VolumeAugust 12, 2024 | marketbeat.comSurModics Hold Rating Amidst Slowing Growth and Pending Acquisition UncertaintyAugust 6, 2024 | markets.businessinsider.comSurmodics (NASDAQ:SRDX) Given Hold Rating at Needham & Company LLCNeedham & Company LLC reissued a "hold" rating on shares of Surmodics in a research note on Monday.August 5, 2024 | marketbeat.comSurmodics, Inc. (NASDAQ:SRDX) Forecasted to Post FY2026 Earnings of $0.87 Per ShareSurmodics, Inc. (NASDAQ:SRDX - Free Report) - Equities researchers at Barrington Research reduced their FY2026 EPS estimates for Surmodics in a research report issued on Thursday, August 1st. Barrington Research analyst M. Petusky now expects that the company will post earnings of $0.87 per shareAugust 5, 2024 | marketbeat.comSRDX Stock Earnings: Surmodics Beats EPS, Beats Revenue for Q3 2024July 31, 2024 | investorplace.comSurmodics Reports Third Quarter of Fiscal Year 2024 Financial ResultsJuly 31, 2024 | finance.yahoo.comSurmodics, Inc. (NASDAQ:SRDX) Shares Acquired by Acadian Asset Management LLCAcadian Asset Management LLC increased its position in Surmodics, Inc. (NASDAQ:SRDX - Free Report) by 11.3% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 408,779 shares of the company's stock after purchasing an additional 41,617 shareJuly 21, 2024 | marketbeat.comShort Interest in Surmodics, Inc. (NASDAQ:SRDX) Increases By 32.4%Surmodics, Inc. (NASDAQ:SRDX - Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 30th, there was short interest totalling 801,600 shares, an increase of 32.4% from the June 15th total of 605,500 shares. Currently, 5.9% of the company's stock are short sold. Based on an average daily trading volume, of 299,900 shares, the short-interest ratio is currently 2.7 days.July 13, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Reaches New 52-Week High at $42.44Surmodics (NASDAQ:SRDX) Sets New 1-Year High at $42.44July 9, 2024 | marketbeat.comSTOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. – SRDXJuly 8, 2024 | globenewswire.comSTOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. - SRDXJuly 3, 2024 | prnewswire.comSurmodics (NASDAQ:SRDX) Sees Large Volume IncreaseSurmodics (NASDAQ:SRDX) Sees Strong Trading VolumeJune 11, 2024 | marketbeat.comSurmodics Awarded Thrombectomy Products Agreement with Premier, Inc.June 10, 2024 | businesswire.comZacks Research Research Analysts Raise Earnings Estimates for Surmodics, Inc. (NASDAQ:SRDX)Surmodics, Inc. (NASDAQ:SRDX - Free Report) - Research analysts at Zacks Research boosted their Q3 2025 earnings per share (EPS) estimates for shares of Surmodics in a report released on Wednesday, May 29th. Zacks Research analyst D. Dey now forecasts that the company will earn $0.11 per share foMay 31, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Downgraded to "Hold" at StockNews.comStockNews.com cut shares of Surmodics from a "buy" rating to a "hold" rating in a research note on Thursday.May 30, 2024 | marketbeat.comSurmodics (NASDAQ:SRDX) Receives "Market Perform" Rating from Barrington ResearchBarrington Research reiterated a "market perform" rating on shares of Surmodics in a report on Thursday.May 30, 2024 | marketbeat.com Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address [Urgent] Starlink Set For The Largest IPO In History? (Ad)He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO. Click here now for the urgent details on this hidden play. SRDX Media Mentions By Week SRDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SRDX News Sentiment▼1.070.56▲Average Medical News Sentiment SRDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SRDX Articles This Week▼72▲SRDX Articles Average Week Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Anika Therapeutics News Today Cytosorbents News Today Vapotherm News Today Integra LifeSciences News Today AtriCure News Today Alphatec News Today Orthofix Medical News Today AngioDynamics News Today Accuray News Today Rockwell Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SRDX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRDX Stock Alerts